Showing 3 results for Visual Acuity
Khajenasiri F, Sotoudeh G,
Volume 65, Issue 14 (3-2008)
Abstract
Background: Healthy vision of workers is one of the important elements in carpet weaving
industry which has essential role in improving of the job quality and efficiency. Visual acuity
is the primary outcome measure in most studies involving eye diseases. Ihe aim of this study
was determination of visual acuity and its effective factors in women carpet weaver in fordu
rural area of Qom has been investigated.
Methods: In a cross-sectional (descriptive-analytical) study visual acuity of 177 women
carpet weaver has been determined. Job hours per day, job history, age, literacy, trauma
history, diabetes history, family history of eye diseases, eye diseases history and family size
of subjects were determined .
Results: The results of study indicated that the right eyes visual acuity of 72.4 % of women
were desirable (0 – 0.8) and 27.6 % were undesirable (0.9-1.2). These results for the left eyes
were 69.5 % and 30.5 % respectively. In addition, the result showed that with increasing the
job hours and history and age, percent of women with undesirable both eyes visual acuity
were increased. With higher literacy levels, percent of women with undesirable both eyes
visual acuity decreased. In subjects with truma history, the undesirable visual acuity was
higher. In this study the relation between visual acuity and job history, age, literacy, truma
history and eye diseases history were statistically significant (in all cases P<0.05).
Conclusions: High percentage of women carpet weaver were in undesirable visual acuity
and in this study the relation between visual acuity and job history, age, literacy, trauma
history and eye diseases history were statistically significant (in all cases P<0.05).
Ali Reza Jafari, Ali Akbar Shafiee , Ali Mirzajani , Peyman Jamali ,
Volume 72, Issue 1 (4-2014)
Abstract
Background: The application of CAM visual stimulation returns to the date of more than fifty years ago. However, the reports of previous studies in this field vary from no effect to significant effects of this method in amblyopia treatment. The purpose of this study was to determine the effect of CAM visual stimulation along with conventional occlusion therapy in anisometropic amblyopic children.
Methods: Forty amblyopic children aged 4 to 6 years old with no previous treatment were enrolled in this randomized clinical trial study. The subjects were randomly as-signed in two different groups. The group 1 included conventional occlusion therapy and group 2 includes occlusion therapy with complementary CAM visual stimulation. In terms of visual acuity and stereopsis improvement and reduction of amblyopia sever-ity, two groups were compared using the repeated measure ANOVA and LSD Post Hoc tests.
Results: In group 1 including conventional occlusion therapy, visual acuity improved from 0.444±0.077 logMAR to 0.138±0.023 logMAR, i.e., improvement of 0.306 log-MAR (P< 0.001) whereas in group 2 including complementary CAM usage, visual acu-ity improved from 0.398±0.075 logMAR to 0.047±0.022 logMAR, i.e., improvement of 0.351 logMAR (P< 0.001). Regarding Stereopsis, the improvements were 157 (from 258±34 to 101±13 seconds of arc, P< 0.001) and 171 (from 237±33 to 66±12 seconds of arc, P< 0.001) for groups 1 and 2 respectively. All subjects of group 2 gained the normal vision at the end of the treatment period, whereas only 47% of subjects of group 1 could achieve this level of vision in that time. Improvement of visual acuity in group 2 was significantly better than group 1 (P< 0.05).
Conclusion: Using of CAM visual stimulation along with conventional occlusion will further improve visual acuity and stereopsis in amblyopic children. These findings recommended the CAM visual stimulation as an accompanying and complementary method in amblyopia treatment.
Ali Salehi , Mohammad-Ali Abtahi , Seyed-Hossein Abtahi , Hasan Razmjou , Mohammad Tohidi , Mojtaba Akbari , Hamidreza Jahanbani-Ardakani ,
Volume 77, Issue 5 (8-2019)
Abstract
Background: Retinal vein occlusions are one of the most common form of retinal vascular disorders and could lead to vision loss due to macular edema, macular ischemia and sequelae from neovascularization. Anti-venous endothelial growth factor (anti-VEGF) treatment is the choice strategy of treatment for patients with macular edema secondary to central retinal vein occlusion (CRVO). There is an evidence of body with the controversies regarding increment of choroidal thickness in CRVO condition. The current study was designed to determine whether baseline subfoveal choroidal thickness may be an indicator for visual and anatomical outcome of bevacizumab in patients with CRVO macular edema.
Methods: This study was a prospective clinical cohort study that enrolled in 23 new cases of treatment-naïve central retinal vein occlusion (CRVO) from February to July 2017 who were visited in Feiz Eye Hospital, Isfahan, Iran. Patients received a single injection of bevacizumab and were followed for 30 days. Ratio of subfoveal choroidal thickness (SFCT) was measured using enhanced depth imaging spectral-domain optical coherence tomography (EDI-OCT). Ratio of SFCT of the CRVO eye to the fellow healthy eye (SFCT1/F) was taken as independent variable. Changes of best-corrected visual acuity (BCVA) in LogMAR (ΔBCVA, functional response) and secondary to baseline central macular thickness ratio (CMT2/1, anatomical response) in the CRVO eyes were taken for comparative and correlative analytics.
Results: A total of 46 eyes from 23 patients with the mean age of 64.60±10.19 years were included in this study. Baseline SFCT was higher in CRVO eyes (251.91±46.09 µm) in comparison to the fellow eye (206.95±26.62, P<0.0001). Also central macular thickness in CRVO eyes were significantly higher in CRVO eyes in comparison with fellow eye (531.04±38.22 vs 303.30±33.59, respectively, P<0.05). SFCT1/F, correlated moderately with anatomical (CMT2/1) and strongly with functional response (ΔBCVA).
Conclusion: Bilateral evaluation of SFCT by EDI-OCT in all newly diagnosed CRVO cases is recommended to determine if there is a relative increase in choroidal thickness. This may help predict short-term response to anti-VEGF therapy.
